Bee product may boost health in oral cancer survivors
NCT ID NCT07682285
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests whether a daily dose of Taiwanese Green Propolis, a natural bee-derived supplement, can improve blood fat levels, reduce fatigue, and enhance quality of life in people who have completed treatment for oral cavity cancer. Participants take either propolis capsules or a placebo for 12 weeks, with follow-up assessments including blood tests, questionnaires, and physical performance measures. The goal is to see if this supplement can help manage common post-treatment issues like high cholesterol and tiredness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Taiwanese Green Propolis (TGP) capsules
What this could lead to
If it works, this could point toward a natural supplement to help manage cholesterol and fatigue after oral cancer treatment.
What could go wrong
This is a small, early-phase trial with only 25 participants, so results may not apply widely. The supplement may not outperform placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dental Outcomes in Head & Neck Cancer Patients (NCT02057510)
- MRG003 + Toripalimab for Head & Neck Cancer Tria NCT07677475
- Acupuncture Timing for Dry Mouth in Head & Neck NCT07674706
- Durvalumab + Radiation for Head & Neck Cancer (NCT03529422)
- PG2 for Chemo Fatigue & Toxicity in Breast Cance NCT03314805
- AI-Assisted Pharmacy Counseling Trial (NCT07649577)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taipei Medical University Hospital
Taipei, Taiwan